A joint venture of the Pharmacy Quality Alliance and CECity, PQS said Friday that, through EQuIPP, Kmart pharmacies will be able to track their performance on a range of quality measures important to health plans. Those include triple-weighted quality measures for Medicare Part D plans plus medication adherence rates included in the new Quality Rating System for health insurance exchanges.
“We are excited at the opportunity to have our pharmacists fully understand the impact that they have on patient care by utilizing the EQuIPP platform,” Kmart Pharmacy president Phil Keough said in a statement. “Our pharmacists have a commitment to the highest standards of quality and look forward to partnering more closely with health plans that are seeking better quality for their members.”
With EQuIPP, Kmart pharmacists also will be able to identify patients with quality-related care gaps to support efforts to optimize the quality of services.
“I’m committed to providing our member patients the best possible care when they put their trust in me, and I’m excited about this new technology, which will allow me to improve my service to them every day,” Kmart pharmacist Brad Lawson commented.
PQS noted that Kmart pharmacists are ready for the shift to quality-focused pharmacy networks and outcome-driven payment models that are gaining traction in the retail pharmacy sector.
“Measuring performance is powerful in transforming the quality of the medication use system, but only if pharmacies have access to standard dashboards that objectively reflect how they compare against meaningful quality measures,” stated David Nau, president of PQS. “Our goal is to accelerate this transformation by making EQuIPP services broadly available so we can rapidly move from measurement to improvement.”
Overall, Kmart has 723 pharmacies in its 979 stores, located in 49 states, Puerto Rico, the U.S. Virgin Islands and Guam.